abrdn Life Sciences Investors SEC filings HQL
abrdn Life Sciences Investors has 519 filings in SEC EDGAR's recent list, going back to Dec 13, 1995. The most recent current report (Form 8-K) was filed on Sep 12, 2023 (auditor change). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| POS AMI | Filing | Oct 15, 2014 | — |
| POS AMI | Filing | Dec 28, 2012 | — |
| POS AMI | Filing | Jul 5, 2011 | — |
| POS AMI | Filing | Jul 18, 2008 | — |
Showing 4 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Listed as
- HQL (NYSE)
- Fiscal year ends
- September 30
- Incorporated in
- MA
- Headquarters
- Philadelphia, PA
- SEC CIK
- 884121
- Former names
- TEKLA LIFE SCIENCES INVESTORS (until Oct 5, 2023); H&Q LIFE SCIENCES INVESTORS (until Sep 18, 2014)
Source: SEC EDGAR filings. This is company-reported data, not investment advice.